List of Tables
Table 1. Urinary System Drugs Market Trends
Table 2. Urinary System Drugs Market Drivers & Opportunity
Table 3. Urinary System Drugs Market Challenges
Table 4. Urinary System Drugs Market Restraints
Table 5. Global Urinary System Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Urinary System Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Urinary System Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Urinary System Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Urinary System Drugs
Table 10. Global Urinary System Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary System Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Urinary System Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Urinary System Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Urinary System Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Urinary System Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Urinary System Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Urinary System Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Urinary System Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Urinary System Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Urinary System Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Urinary System Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Urinary System Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Urinary System Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Urinary System Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Urinary System Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Urinary System Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Urinary System Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Urinary System Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Urinary System Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Johnson & Johnson Basic Information List
Table 32. Johnson & Johnson Description and Business Overview
Table 33. Johnson & Johnson Urinary System Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Urinary System Drugs Business of Johnson & Johnson (2019-2024)
Table 35. Johnson & Johnson Recent Developments
Table 36. Bayer Basic Information List
Table 37. Bayer Description and Business Overview
Table 38. Bayer Urinary System Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Urinary System Drugs Business of Bayer (2019-2024)
Table 40. Bayer Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Urinary System Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Urinary System Drugs Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. GSK Basic Information List
Table 47. GSK Description and Business Overview
Table 48. GSK Urinary System Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Urinary System Drugs Business of GSK (2019-2024)
Table 50. GSK Recent Developments
Table 51. Boehringer Ingelheim Basic Information List
Table 52. Boehringer Ingelheim Description and Business Overview
Table 53. Boehringer Ingelheim Urinary System Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Urinary System Drugs Business of Boehringer Ingelheim (2019-2024)
Table 55. Boehringer Ingelheim Recent Developments
Table 56. Roche Basic Information List
Table 57. Roche Description and Business Overview
Table 58. Roche Urinary System Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Urinary System Drugs Business of Roche (2019-2024)
Table 60. Roche Recent Developments
Table 61. Novartis Basic Information List
Table 62. Novartis Description and Business Overview
Table 63. Novartis Urinary System Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Urinary System Drugs Business of Novartis (2019-2024)
Table 65. Novartis Recent Developments
Table 66. AstraZeneca Basic Information List
Table 67. AstraZeneca Description and Business Overview
Table 68. AstraZeneca Urinary System Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Urinary System Drugs Business of AstraZeneca (2019-2024)
Table 70. AstraZeneca Recent Developments
Table 71. Dr. Reddy’s Laboratories Basic Information List
Table 72. Dr. Reddy’s Laboratories Description and Business Overview
Table 73. Dr. Reddy’s Laboratories Urinary System Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Urinary System Drugs Business of Dr. Reddy’s Laboratories (2019-2024)
Table 75. Dr. Reddy’s Laboratories Recent Developments
Table 76. Mylan Basic Information List
Table 77. Mylan Description and Business Overview
Table 78. Mylan Urinary System Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Urinary System Drugs Business of Mylan (2019-2024)
Table 80. Mylan Recent Developments
Table 81. Sun Pharma Basic Information List
Table 82. Sun Pharma Description and Business Overview
Table 83. Sun Pharma Urinary System Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Urinary System Drugs Business of Sun Pharma (2019-2024)
Table 85. Sun Pharma Recent Developments
Table 86. Cipla Basic Information List
Table 87. Cipla Description and Business Overview
Table 88. Cipla Urinary System Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Urinary System Drugs Business of Cipla (2019-2024)
Table 90. Cipla Recent Developments
Table 91. Merck Basic Information List
Table 92. Merck Description and Business Overview
Table 93. Merck Urinary System Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Urinary System Drugs Business of Merck (2019-2024)
Table 95. Merck Recent Developments
Table 96. Cubist Pharmaceuticals Basic Information List
Table 97. Cubist Pharmaceuticals Description and Business Overview
Table 98. Cubist Pharmaceuticals Urinary System Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Urinary System Drugs Business of Cubist Pharmaceuticals (2019-2024)
Table 100. Cubist Pharmaceuticals Recent Developments
Table 101. Abbott Laboratories Basic Information List
Table 102. Abbott Laboratories Description and Business Overview
Table 103. Abbott Laboratories Urinary System Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Urinary System Drugs Business of Abbott Laboratories (2019-2024)
Table 105. Abbott Laboratories Recent Developments
Table 106. Eli Lilly Basic Information List
Table 107. Eli Lilly Description and Business Overview
Table 108. Eli Lilly Urinary System Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Urinary System Drugs Business of Eli Lilly (2019-2024)
Table 110. Eli Lilly Recent Developments
Table 111. Melinta Therapeutics Basic Information List
Table 112. Melinta Therapeutics Description and Business Overview
Table 113. Melinta Therapeutics Urinary System Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Urinary System Drugs Business of Melinta Therapeutics (2019-2024)
Table 115. Melinta Therapeutics Recent Developments
Table 116. Sanofi Basic Information List
Table 117. Sanofi Description and Business Overview
Table 118. Sanofi Urinary System Drugs Products, Services and Solutions
Table 119. Revenue (US$ Million) in Urinary System Drugs Business of Sanofi (2019-2024)
Table 120. Sanofi Recent Developments
Table 121. Daiichi Sankyo Basic Information List
Table 122. Daiichi Sankyo Description and Business Overview
Table 123. Daiichi Sankyo Urinary System Drugs Products, Services and Solutions
Table 124. Revenue (US$ Million) in Urinary System Drugs Business of Daiichi Sankyo (2019-2024)
Table 125. Daiichi Sankyo Recent Developments
Table 126. Lupin Basic Information List
Table 127. Lupin Description and Business Overview
Table 128. Lupin Urinary System Drugs Products, Services and Solutions
Table 129. Revenue (US$ Million) in Urinary System Drugs Business of Lupin (2019-2024)
Table 130. Lupin Recent Developments
Table 131. Apogepha Basic Information List
Table 132. Apogepha Description and Business Overview
Table 133. Apogepha Urinary System Drugs Products, Services and Solutions
Table 134. Revenue (US$ Million) in Urinary System Drugs Business of Apogepha (2019-2024)
Table 135. Apogepha Recent Developments
Table 136. Astellas Pharma Basic Information List
Table 137. Astellas Pharma Description and Business Overview
Table 138. Astellas Pharma Urinary System Drugs Products, Services and Solutions
Table 139. Revenue (US$ Million) in Urinary System Drugs Business of Astellas Pharma (2019-2024)
Table 140. Astellas Pharma Recent Developments
Table 141. Dr. Dunner Basic Information List
Table 142. Dr. Dunner Description and Business Overview
Table 143. Dr. Dunner Urinary System Drugs Products, Services and Solutions
Table 144. Revenue (US$ Million) in Urinary System Drugs Business of Dr. Dunner (2019-2024)
Table 145. Dr. Dunner Recent Developments
Table 146. Kowa Basic Information List
Table 147. Kowa Description and Business Overview
Table 148. Kowa Urinary System Drugs Products, Services and Solutions
Table 149. Revenue (US$ Million) in Urinary System Drugs Business of Kowa (2019-2024)
Table 150. Kowa Recent Developments
Table 151. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information List
Table 152. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Description and Business Overview
Table 153. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Products, Services and Solutions
Table 154. Revenue (US$ Million) in Urinary System Drugs Business of Jiangxi Jimin Kexin Jinshuibao Pharmaceutical (2019-2024)
Table 155. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Developments
Table 156. Tianjin Tongrentang Group Basic Information List
Table 157. Tianjin Tongrentang Group Description and Business Overview
Table 158. Tianjin Tongrentang Group Urinary System Drugs Products, Services and Solutions
Table 159. Revenue (US$ Million) in Urinary System Drugs Business of Tianjin Tongrentang Group (2019-2024)
Table 160. Tianjin Tongrentang Group Recent Developments
Table 161. Jiangsu Hengrui Pharmaceutical Basic Information List
Table 162. Jiangsu Hengrui Pharmaceutical Description and Business Overview
Table 163. Jiangsu Hengrui Pharmaceutical Urinary System Drugs Products, Services and Solutions
Table 164. Revenue (US$ Million) in Urinary System Drugs Business of Jiangsu Hengrui Pharmaceutical (2019-2024)
Table 165. Jiangsu Hengrui Pharmaceutical Recent Developments
Table 166. Hunan Qianjin Xiang River Pharmaceutical Basic Information List
Table 167. Hunan Qianjin Xiang River Pharmaceutical Description and Business Overview
Table 168. Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Products, Services and Solutions
Table 169. Revenue (US$ Million) in Urinary System Drugs Business of Hunan Qianjin Xiang River Pharmaceutical (2019-2024)
Table 170. Hunan Qianjin Xiang River Pharmaceutical Recent Developments
Table 171. Kunming Jida Pharmaceutical Basic Information List
Table 172. Kunming Jida Pharmaceutical Description and Business Overview
Table 173. Kunming Jida Pharmaceutical Urinary System Drugs Products, Services and Solutions
Table 174. Revenue (US$ Million) in Urinary System Drugs Business of Kunming Jida Pharmaceutical (2019-2024)
Table 175. Kunming Jida Pharmaceutical Recent Developments
Table 176. Jiangsu Lianhuan Pharmaceutical Basic Information List
Table 177. Jiangsu Lianhuan Pharmaceutical Description and Business Overview
Table 178. Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Products, Services and Solutions
Table 179. Revenue (US$ Million) in Urinary System Drugs Business of Jiangsu Lianhuan Pharmaceutical (2019-2024)
Table 180. Jiangsu Lianhuan Pharmaceutical Recent Developments
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Urinary System Drugs Downstream Customers
Table 184. Urinary System Drugs Distributors List
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
Table 188. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Urinary System Drugs Product Picture
Figure 2. Global Urinary System Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Urinary System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Urinary System Drugs Report Years Considered
Figure 5. Global Urinary System Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Urinary System Drugs Revenue in 2023
Figure 7. Urinary System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Injection Picture
Figure 9. Tablets Picture
Figure 10. Capsule Picture
Figure 11. Suppository Picture
Figure 12. Granules Picture
Figure 13. Powder Picture
Figure 14. Pills Picture
Figure 15. Cream Picture
Figure 16. Others Picture
Figure 17. Global Urinary System Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Urinary System Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 19. Product Picture of Kidney Disease Medication
Figure 20. Product Picture of Medication For Prostate Disease
Figure 21. Product Picture of Male Dysfunction
Figure 22. Product Picture of Lithotripsy Drug
Figure 23. Product Picture of Others
Figure 24. Global Urinary System Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Urinary System Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 26. North America Urinary System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Urinary System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Urinary System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Urinary System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Urinary System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Urinary System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Urinary System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Urinary System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Urinary System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Urinary System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Urinary System Drugs Sales Value (%), (2019-2030)
Figure 37. United States Urinary System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Urinary System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Urinary System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Urinary System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Urinary System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Urinary System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. China Urinary System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Urinary System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. China Urinary System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Urinary System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Urinary System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Urinary System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Urinary System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Urinary System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Urinary System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Urinary System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Urinary System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Urinary System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. India Urinary System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Urinary System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. India Urinary System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. Urinary System Drugs Industrial Chain
Figure 59. Urinary System Drugs Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
